JOINT FILING AGREEMENT
EXHIBIT 99.1
The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of Tesla, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned.
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
Dated this 24th day of April, 2020.
|
By: /s/ Xxx Xxxxxx Xxx Xxxxxx, Authorized Signatory
|
CITADEL ADVISORS LLC
By: /s/ Xxxx Xxxxxxxx Xxxx Xxxxxxxx, Authorized Signatory
|
|
CALC IV LP
By: /s/ Xxx Xxxxxx Xxx Xxxxxx, Authorized Signatory
|
CITADEL ADVISORS HOLDINGS LP
By: /s/ Xxxx Xxxxxxxx Xxxx Xxxxxxxx, Authorized Signatory
|
|
CITADEL SECURITIES GP LLC
By: /s/ Xxx Xxxxxx Xxx Xxxxxx, Authorized Signatory
|
CITADEL GP LLC
By: /s/ Xxxx Xxxxxxxx Xxxx Xxxxxxxx, Authorized Signatory |
|
XXXXXXX XXXXXXX
By: /s/ Xxxx Xxxxxxxx Xxxx Xxxxxxxx, attorney-in-fact* |
| * | Xxxx Xxxxxxxx is signing on behalf of Xxxxxxx Xxxxxxx as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Zentalis Pharmaceuticals Inc. on April 9, 2020. |
